IBIO

iBio, Inc. [IBIO] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

IBIO Stock Summary

Top 10 Correlated ETFs

IBIO


Top 10 Correlated Stocks

IBIO


In the News

02:43 29 Mar 2024 IBIO

iBio stock nearly tripled on Wednesday: here's why

Shares of iBio Inc (NYSEAMERICAN: IBIO) close to tripled on Wednesday after the biotechnology company announced a collaboration with AstralBio Inc.

11:54 29 Mar 2024 IBIO

iBio partners with AstralBio to develop obesity treatments using AI-driven platform

iBio, an AI-driven drug developer, shares surged more than 120% after it announced it has entered into a collaboration agreement with private biotech firm AstralBio to discover, engineer and develop novel antibodies to treat obesity and other cardiometabolic conditions. The company said the collaboration brings together its ability to create antibodies against hard-to-drug targets using its patented Generative AI and machine learning platform with AstralBio's experience in biologics and drug development.

10:04 29 Mar 2024 IBIO

Why Is iBio (IBIO) Stock Up 125% Today?

iBio‘s (NYSEMKT: IBIO ) shares are trending, and IBIO stock is up 125% today after the firm used two of the market's favorite buzzwords — artificial intelligence (AI) and obesity drugs — in a press release that unveiled a new initiative. Specifically, the firm announced that its AI drug discovery platform would be used to develop obesity treatments.

08:48 29 Mar 2024 IBIO

Why Is iBio (IBIO) Stock Down 41% Today?

Ibio (NYSEMKT: IBIO ) stock is falling hard on Tuesday after the biotechnology company announced the pricing of a public share offering. That offering has the company selling 2.25 million shares of IBIO stock for $2 each.

04:06 29 Mar 2024 IBIO

Ticking Time Bombs: 3 Healthcare Stocks to Dump Before the Damage Is Done

The healthcare industry has historically provided significant returns to investors. And, it is currently boasting a compounding annual growth rate prediction of 10.4% until 2027.

09:40 29 Mar 2024 IBIO

Why Is iBio (IBIO) Stock Up 16% Today?

Ibio (NYSEMKT: IBIO ) stock is rising higher on Tuesday as investors react to the company reaching a research collaboration agreement with the NIH. This will see the company teaming up with the NIH's National Institute of Allergy and Infectious Diseases (NIAID).

02:14 29 Mar 2024 IBIO

Penny Stocks To Buy Now? 3 Short Squeeze Stock To Watch

Short squeeze penny stocks for your watch list. The post Penny Stocks To Buy Now?

06:20 29 Mar 2024 IBIO

7 Stocks to Sell as Banks Melt Down

Peruse the Internet for investment guidance and you're likely to hear the adage that you shouldn't consider stocks to sell when faced with volatility. Rather, you should buy up assets and securities when there's blood on the streets.

10:44 29 Mar 2024 IBIO

4 Top Penny Stocks To Watch With Big Biotech News This Quarter

4 biotech penny stocks to watch right now. The post 4 Top Penny Stocks To Watch With Big Biotech News This Quarter appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

11:52 29 Mar 2024 IBIO

Penny Stocks To Buy: 5 To Watch Before Next Week

Penny stocks to watch this week. The post Penny Stocks To Buy: 5 To Watch Before Next Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

IBIO Financial details

Company Rating
Neutral
Market Cap
3.8M
Income
-26.3M
Revenue
50K
Book val./share
4.96
Cash/share
1.5
Dividend
-
Dividend %
-
Employees
26
Optionable
No
Shortable
Yes
Earnings
13 May 2024
P/E
-0.62
Forward P/E
-0.19
PEG
1.01
P/S
37.37
P/B
2.41
P/C
2.71
P/FCF
-0.07
Quick Ratio
0.07
Current Ratio
1.11
Debt / Equity
1.79
LT Debt / Equity
0.34
-
-
EPS (TTM)
-5.49
EPS next Y
-21.8
EPS next Q
1.58
EPS this Y
-59.15%
EPS next Y
297.09%
EPS next 5Y
-
EPS last 5Y
-36.55%
Revenue last 5Y
-100%
Revenue Q/Q
-
EPS Q/Q
1741.67%
-
-
-
-
SMA20
38.02%
SMA50
38.02%
SMA100
-70.07%
Inst Own
0.08%
Inst Trans
0%
ROA
-137%
ROE
-319%
ROC
-1.58%
Gross Margin
100%
Oper. Margin
-53620%
Profit Margin
-103292%
Payout
-
Shs Outstand
3.48M
Shs Float
3.47M
-
-
-
-
Target Price
-
52W Range
1.02-49.8
52W High
-91.71%
52W Low
+306%
RSI
95.48
Rel Volume
493.49
Avg Volume
102.08K
Volume
50.37M
Perf Week
283.02%
Perf Month
235.54%
Perf Quarter
-27.5%
Perf Half Y
-32.33%
-
-
-
-
Beta
-3.796
-
-
Volatility
1.19%, 0.64%
Prev Close
20.83%
Price
4.06
Change
50.37%

IBIO Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-06-30

Metric History 2019-06-302020-06-302021-06-302022-06-30 2023-06-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
2.670.650.30.270
Net income per share
-23.24-7.53-2.97-5.85-2.39
Operating cash flow per share
-18.46-5.31-3.84-4.3-2.49
Free cash flow per share
-19.77-5.77-4.5-5.63-2.95
Cash per share
5.8421.9412.393.840.35
Book value per share
3.2522.5413.887.281.26
Tangible book value per share
1.4322.0813.756.720.82
Share holders equity per share
3.2522.5413.887.281.26
Interest debt per share
35.3814.084.53.351.39
Market cap
264.96M2.79B5.91B1.13B149.39M
Enterprise value
285.43M2.77B5.86B1.14B162.16M
P/E ratio
-15.06-147.4-254-22.23-5.1
Price to sales ratio
131.31.7K2.49K475.760
POCF ratio
-18.96-208.92-196.51-30.25-4.91
PFCF ratio
-17.71-192.3-167.71-23.09-4.13
P/B Ratio
107.5849.2454.4117.869.71
PTB ratio
107.5849.2454.4117.869.71
EV to sales
141.441.69K2.47K477.90
Enterprise value over EBITDA
-20.46-235.66-189.39-24.92-5.53
EV to operating cash flow
-20.42-207.26-195.02-30.39-5.33
EV to free cash flow
-19.07-190.76-166.45-23.19-4.48
Earnings yield
-0.07-0.010-0.04-0.2
Free cash flow yield
-0.06-0.01-0.01-0.04-0.24
Debt to equity
10.10.580.30.441.11
Debt to assets
0.810.350.220.280.41
Net debt to EBITDA
-1.471.891.44-0.11-0.44
Current ratio
1.3911.7915.741.481.22
Interest coverage
-8.31-5.68-12.68-35.19353.14
Income quality
0.790.811.30.750.47
Dividend Yield
00.01000
Payout ratio
0-1.1400-0.02
Sales general and administrative to revenue
6.117.599.2914.320
Research and developement to revenue
2.711.964.217.440
Intangibles to total assets
0.040.010.010.050.13
Capex to operating cash flow
0.070.090.170.310.19
Capex to revenue
-0.49-0.7-2.18-4.880
Capex to depreciation
-0.57-0.51-2.14-3.07-4.16
Stock based compensation to revenue
0.120.240.671.840
Graham number
41.2561.830.4630.958.23
ROIC
-0.3-0.13-0.18-0.52-0.76
Return on tangible assets
-0.6-0.2-0.16-0.54-0.82
Graham Net
-31.228.828.020.47-0.88
Working capital
1.35M56.51M97.95M14.63M4.68M
Tangible asset value
1.08M55.46M107.62M58.63M9.99M
Net current asset value
-23.32M24.17M66.2M9.15M433K
Invested capital
10.10.580.30.441.11
Average receivables
86K2.86M5.58M5.81M3.15M
Average payables
895.5K1.38M2.01M3.26M3.06M
Average inventory
0.5399K412.5K1.96M12.5M
Days sales outstanding
17.541.25K850.69934.330
Days payables outstanding
0913.28562.737.21K610.2
Days of inventory on hand
0414.326.746.59K6.96K
Receivables turnover
20.80.290.430.390
Payables turnover
00.40.650.050.6
Inventory turnover
00.8854.150.060.05
ROE
-7.14-0.33-0.21-0.8-1.91
Capex per share
-1.31-0.46-0.66-1.33-0.47

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q2

Metric History 2022-12-312023-03-312023-06-302023-09-30 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
00000
Net income per share
-3.43-0.48-0.35-0.24-4.42
Operating cash flow per share
-0.78-0.29-0.29-0.22-2.54
Free cash flow per share
-1.08-0.28-0.32-0.22-2.54
Cash per share
0.980.50.250.061.5
Book value per share
1.921.320.890.554.96
Tangible book value per share
1.370.910.580.332.06
Share holders equity per share
1.921.320.890.554.96
Interest debt per share
2.091.370.990.698.89
Market cap
86.07M548.45M209.89M143.81M2.54M
Enterprise value
102.77M559.88M222.66M158.96M16.22M
P/E ratio
-0.64-21.72-8.7-6.26-0.08
Price to sales ratio
0002.88K0
POCF ratio
-11.27-141.65-42.23-26.93-0.54
PFCF ratio
-8.13-149.4-38.33-26.93-0.54
P/B Ratio
4.5731.5413.6510.890.28
PTB ratio
4.5731.5413.6510.890.28
EV to sales
0003.18K0
Enterprise value over EBITDA
-10.04-93.91-48.3-33.61-3.92
EV to operating cash flow
-13.46-144.6-44.8-29.77-3.45
EV to free cash flow
-9.71-152.51-40.66-29.77-3.45
Earnings yield
-0.39-0.01-0.03-0.04-3.23
Free cash flow yield
-0.12-0.01-0.03-0.04-1.85
Debt to equity
1.081.031.111.261.79
Debt to assets
0.390.410.410.440.48
Net debt to EBITDA
-1.63-1.92-2.77-3.2-3.31
Current ratio
1.381.221.221.110.91
Interest coverage
-341.06-176.26-292.06-196.27-132.24
Income quality
0.230.530.820.930.57
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00070.940
Research and developement to revenue
00032.120
Intangibles to total assets
0.10.120.130.140.16
Capex to operating cash flow
0.39-0.050.100
Capex to revenue
00000
Capex to depreciation
-9.880.71-1.6600
Stock based compensation to revenue
00015.30
Graham number
12.193.772.661.7222.21
ROIC
-0.77-0.16-0.17-0.17-0.15
Return on tangible assets
-0.72-0.16-0.17-0.18-0.29
Graham Net
-0.75-0.78-0.63-0.96-7.32
Working capital
10.46M4.82M4.68M2.31M-1.85M
Tangible asset value
13.43M12M9.99M7.83M3.82M
Net current asset value
5.26M96K433K-1.45M-5.13M
Invested capital
1.081.031.111.261.79
Average receivables
6.95M4.49M723K102K875K
Average payables
4.4M3.01M1.93M1.88M1.89M
Average inventory
10.7M19.41M19.73M10.55M7.13M
Days sales outstanding
00000
Days payables outstanding
1.2K642.455.37K687.96432.33
Days of inventory on hand
6.16K5.86K61.23K03.32K
Receivables turnover
00000
Payables turnover
0.070.140.020.130.21
Inventory turnover
0.010.02000.03
ROE
-1.78-0.36-0.39-0.44-0.89
Capex per share
-0.30.02-0.0300

IBIO Frequently Asked Questions

What is iBio, Inc. stock symbol ?

iBio, Inc. is a US stock , located in Bryan of Tx and trading under the symbol IBIO

What is iBio, Inc. stock quote today ?

iBio, Inc. stock price is $4.06 today.

Is iBio, Inc. stock public?

Yes, iBio, Inc. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap